Healius Ltd (PHCRF)
2.13
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Healius Price to Book Value: 2.161 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 31, 2024 | 2.161 |
May 30, 2024 | 2.161 |
May 29, 2024 | 2.161 |
May 28, 2024 | 2.161 |
May 24, 2024 | 2.161 |
May 23, 2024 | 2.161 |
May 22, 2024 | 2.161 |
May 21, 2024 | 2.161 |
May 20, 2024 | 2.161 |
May 17, 2024 | 2.161 |
May 16, 2024 | 2.161 |
May 15, 2024 | 2.161 |
May 14, 2024 | 2.161 |
May 13, 2024 | 2.161 |
May 10, 2024 | 2.161 |
May 09, 2024 | 2.161 |
May 08, 2024 | 2.161 |
May 07, 2024 | 2.161 |
May 06, 2024 | 2.161 |
May 03, 2024 | 2.161 |
May 02, 2024 | 2.161 |
May 01, 2024 | 2.161 |
April 30, 2024 | 2.161 |
April 29, 2024 | 2.161 |
April 26, 2024 | 2.161 |
Date | Value |
---|---|
April 25, 2024 | 2.161 |
April 24, 2024 | 2.161 |
April 23, 2024 | 2.161 |
April 22, 2024 | 2.161 |
April 19, 2024 | 2.161 |
April 18, 2024 | 2.161 |
April 17, 2024 | 2.161 |
April 16, 2024 | 2.161 |
April 15, 2024 | 2.161 |
April 12, 2024 | 2.161 |
April 11, 2024 | 2.161 |
April 10, 2024 | 2.161 |
April 09, 2024 | 2.161 |
April 08, 2024 | 2.161 |
April 05, 2024 | 2.161 |
April 04, 2024 | 2.161 |
April 03, 2024 | 2.161 |
April 02, 2024 | 2.161 |
April 01, 2024 | 2.161 |
March 28, 2024 | 2.161 |
March 27, 2024 | 2.161 |
March 26, 2024 | 2.161 |
March 25, 2024 | 2.161 |
March 22, 2024 | 2.161 |
March 21, 2024 | 2.161 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9289
Minimum
Dec 31 2020
2.161
Maximum
Jan 02 2024
1.146
Average
1.028
Median
Jul 13 2021
Price to Book Value Benchmarks
Alterity Therapeutics Ltd | -- |
Kazia Therapeutics Ltd | 1.980 |
Immutep Ltd | -- |
Opthea Ltd | -- |
Mesoblast Ltd | -- |
Price to Book Value Related Metrics
PS Ratio | 1.155 |
Price | 2.13 |
Earnings Yield | -49.99% |
Market Cap | 1.547B |
Operating PE Ratio | 26.52 |